CON Concentra Group Holdings Parent, Inc.

Wall Street Zen has upgraded Concentra Group Holdings Parent (NYSE:CON) from "hold" to "buy," contributing to a consensus "Moderate Buy" rating with an average price target of $27.75. The company recently reported $0.37 EPS and $489.6 million in quarterly revenue, trading with a market capitalization of $2.57 billion and a P/E of 16.73. Institutional investors like American Century and Raymond James have increased their stakes, indicating positive sentiment and recent inflows.

Zacks Research has upgraded Concentra Group Holdings Parent (NYSE:CON) from a "strong sell" to a "hold" rating. This upgrade aligns with other positive analyst views, including JPMorgan's "overweight" rating and a consensus "Moderate Buy" rating with an average $27.75 target price. The article highlights recent institutional investment, solid Q3 financial results with $0.37 EPS on $489.64 million revenue, and a 48.42% ROE.

Concentra Group Holdings Parent, Inc. (NYSE:CON) has received a "Moderate Buy" consensus rating from six analysts, with an average 12-month price target of $27.75. The company recently reported quarterly EPS of $0.37 on $489.6 million in revenue, an ROE of 48.42%, and pays a quarterly dividend of $0.0625. Institutional investors like Barrow Hanley and Woodline Partners have shown significant interest, increasing their stakes in the company.

This article examines Concentra Group Holdings Parent, Inc.'s (NYSE:CON) Return on Equity (ROE) of 39%, comparing it to the Healthcare industry average of 15%. While the high ROE is positive, the analysis reveals that it is significantly boosted by the company's high debt-to-equity ratio of 3.94, suggesting the profitability might be less efficient without substantial leverage. Investors are advised to consider debt levels and other financial factors when evaluating the stock.

Thrivent Financial for Lutherans has reduced its stake in Concentra Group Holdings Parent, Inc. by 8.4% in the second quarter, selling 210,449 shares. Despite this, they still own 2,300,475 shares valued at approximately $47.32 million. Concentra Group Holdings Parent (NYSE:CON) reported $0.37 EPS and quarterly revenue of $489.64 million, with the stock trading near $19.89 and analysts maintaining a "Moderate Buy" consensus.

Concentra, a leader in occupational medicine, has opened a new medical center in Hialeah, Florida, located at 855 East 8th Avenue. This expansion aims to serve more employers and enhance access to occupational health services, including work injury care, physical therapy, and drug testing. The new center also offers telemedicine options through Concentra Telemed®.